Elizabeth C. Smyth Journalist Profile

Articles

Jamie Oliver wrote First Nations characters the wrong way. Non-Indigenous writers need to listen to Indigenous writers first

Nov 10, 2024 | theconversation.com | Jeanine Leane |Elizabeth C. Smyth

First Nations authored literature continues to excite and educate Australian readers. Non-Indigenous writers are grappling with how to craft inclusive fiction that does not impinge on Indigenous knowledge, beliefs and rights of self-representation. Inclusive fiction is central to a representative literary landscape. In settler colonies such as Australia, this comes with the danger of cultural appropriation.
Alone together

Mar 14, 2024 | meanjin.com.au | Elizabeth C. Smyth

It’s Saturday. Lunchtime. Michael crouches over roast meat and vegies. He stares at Kayla the way he does when he doesn’t get his way. His mouth opens as he chews, and skin crawls up his nose. Kayla pretends not to see. She looks instead at the shoes on the new waitress. They’re a bit too fucken shiny for this joint. The siblings gulp anything that passes as food. Cane toads do the same. Kayla slips her feet from her thongs. She could do with some new ones. Michael lets out a grinding fart.
New approaches show promise for treatment of gastroesophageal cancers

Jan 25, 2024 | healio.com | Jennifer Southall |Mindy Valcarcel |Elizabeth C. Smyth

Elizabeth C. Smyth, MD CLDN18.2 is a young target and we do not yet fully understand its interaction with other biomarkers. However, it is a bystander in carcinogenesis and nonprognostic. This year, two phase 2/phase 3 randomized trials are evaluating CLDN18.2, a therapeutic targeted at gastroesophageal cancer, including the results from the phase 1 trial of CMG901 in patients with advanced gastric and gastroesophageal junction cancer.
Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a

Jun 14, 2023 | thelancet.com | Eric Van Cutsem |Maria Di Bartolomeo |Elizabeth C. Smyth |Ian Chau

Cookie Preference CenterWe use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our Cookie Policy and the list of Google Ad-Tech Vendors. You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer.